Publication of Supplement

RNS Number : 7817E
Lloyds Banking Group PLC
05 November 2015
 

5 November 2015

 

Publication of Supplementary Prospectus

The following Supplementary Prospectus has been approved by the UK Listing Authority and is available for viewing:

Supplementary Prospectus dated 5 November 2015 (the "Supplementary Prospectus") relating to the £50,000,000,000 Euro Medium Term Note Programme of Lloyds Bank plc and Lloyds Banking Group plc

The Supplementary Prospectus should be read and construed in conjunction with the base prospectus dated 9 April 2015 and the supplementary prospectuses dated 11 May 2015 and 12 August 2015 (the "Base Prospectus").

To view the Supplementary Prospectus, please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/7817E_-2015-11-5.pdf

The Supplementary Prospectus has been submitted to the National Storage Mechanism and will shortly be available for inspection at: www.Hemscott.com/nsm.do.

For further information, please contact:

 

Matthew Young
Group Corporate Affairs Director
Tel:      +44 (0) 20 7356 2231
Email:  matt.young@lloydsbanking.com

Investor Relations:

Douglas Radcliffe
Investor Relations Director 

Tel:      +44 20 7356 1571

Email:  douglas.radcliffe@finance.lloydsbanking.com

 

Lloyds Bank plc
Registered Office
25 Gresham Street
London
EC2V 7HN

Lloyds Banking Group plc
Registered Office
The Mound
Edinburgh
EH1 1YZ

 

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in this announcement and the Supplementary Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom this announcement and the Supplementary Prospectus are not addressed. Prior to relying on the information contained in this announcement and the Supplementary Prospectus, you must ascertain from the Base Prospectus whether or not you are one of the intended addressees of the information contained in this announcement and the Supplementary Prospectus.

In particular, this announcement and the Supplementary Prospectus do not constitute an offer or invitation to subscribe for, or purchase, securities in the United States or in any other jurisdiction where such an offer or invitation would be unlawful. This announcement and the Supplementary Prospectus are not for distribution in the United States. The securities described herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or under any relevant securities laws of any state of the United States of America and are subject to U.S. tax law requirements. Subject to certain exceptions, the securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons or to persons within the United States of America, as such terms are defined in Regulation S under the Securities Act. There will be no public offering of the securities in the United States. For a description of the restrictions on offers and sales of the securities described herein, please refer to the Supplementary Prospectus and Base Prospectus.

Your right to access this service is conditional upon complying with the above requirement.

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PDIDELFBEFFEFBK
UK 100

Latest directors dealings